Skip to main navigation Skip to search Skip to main content

Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms

    Research output: Contribution to journal › Article (Academic Journal) › peer-review

    304 Citations (Scopus)
    603 Downloads (Pure)

    Abstract

    Diabetes mellitus (DM) is the major cause of end-stage renal disease (ESRD) globally, and novel treatments are urgently needed. Current therapeutic approaches for diabetic nephropathy (DN) are focussing on blood pressure control with inhibitors of the renin–angiotensin–aldosterone system, on glycaemic and lipid control, and life-style changes. In this review, we highlight new molecular insights aiding our understanding of the initiation and progression of DN, including glomerular insulin resistance, dysregulation of cellular substrate utilisation, podocyte–endothelial communication, and inhibition of tubular sodium coupled glucose reabsorption. We believe that these mechanisms offer new therapeutic targets that can be exploited to develop important renoprotective treatments for DN over the next decade.
    Original languageEnglish
    Pages (from-to)820-830
    Number of pages11
    JournalTrends in Endocrinology and Metabolism
    Volume27
    Issue number11
    Early online date25 Jul 2016
    DOIs
    Publication statusPublished - 10 Nov 2016

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Research Groups and Themes

    • Bristol BioDesign Institute

    Keywords

    • diabetes
    • synthetic biology
    • SGLT2
    • oxidative stress
    • glomerulus
    • endothelium
    • podocytes

    Fingerprint

    Dive into the research topics of 'Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms'. Together they form a unique fingerprint.

    Cite this